QurieGen B.V.
- Biotech or pharma, therapeutic R&D
- Other R&D services
QurieGen, a spin-off from Radboud University in Nijmegen, creates a faster and more affordable way to develop effective treatments. Our platform combines proprietary methods of mapping cellular responses, single-cell genomics, and data science to build predictive models of disease biology and drug response to de-risk and accelerate traditional drug discovery and development. QuRIE-seq technology offers unique insights into how diseased cells behave and respond to drugs, illuminating the complexities of biological systems.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}